COVID19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: 1 Tab resveratrol (500mg) from Sumabe, daily until 14 days in addition to routine drugs. Intervention 2: Control group: this group doesn't receive extra drugs and
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Polymerase chain reaction (PCR) confirmed infection with SARS CoV2 Lung involvement confirmed with chest imaging Hospitalized with: Fever (axillar or oral temperature = 38.0 °centigrade(C) or =38.6°centigrade tympanic or rectal) or Respiratory rate >24/min Or Cough Less than 8 days since illness onset Willingness of study participant to accept random assignment to any treatment arm Acceptance of non-participation in another study before the 28th day of the study
Exclusion criteria
Exclusion criteria: Autoimmune diseases (lupus, MS, etc.) Hepatic failure Hepatit B and C pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery time. Timepoint: Duration of treatment. Method of measurement: Evaluation of clinical symptoms.;Repiratory signs. Timepoint: daily. Method of measurement: clinical evaluation and questionnaire.;Pulmonary Condition. Timepoint: Before intervention and 14 days after intervention. Method of measurement: CT scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood oxygen saturation percentage. Timepoint: Before and 14 days after starting treatment. Method of measurement: Pulse oximeter.;C-Reactive Protein (CRP). Timepoint: Before and fourteen days after starting treatment. Method of measurement: ?ELISA (enzyme-linked immunosorbent assay).;IL6. Timepoint: Before and 14 days after starting treatment. Method of measurement: ELISA (enzyme-linked immunosorbent assay).;IL1. Timepoint: Before and 14 days after starting treatment. Method of measurement: ELISA (enzyme-linked immunosorbent assay).;CBC. Timepoint: Before and 14 days after starting treatment. Method of measurement: Cell Counter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArash Alghasi
Ahvaz University of Medical Sciences
Outcome results
None listed